The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation system

被引:0
|
作者
JC Fox
J England
P White
G Ellison
K Callaghan
NR Charlesworth
J Hehir
TL McCarthy
J Smith-Ravin
IC Talbot
D Snary
JMA Northover
CR Newton
S Little
机构
[1] Zeneca Diagnostics,
来源
British Journal of Cancer | 1998年 / 77卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A total of 301 colorectal carcinoma (CRC) archival samples were analysed using the amplification-refractory mutation system (ARMS). Each sample was examined to determine the mutation status of codons 12 and 13 of the K-ras oncogene. The results from direct DNA sequence analysis carried out on 30 of the samples differed from the ARMS result in almost 50% of the cases as a result of the relative excess of wild-type to mutated DNA sequences. To assess the validity of the ARMS data, the polymerase chain reaction (PCR) was used to generate an amplicon from K-ras exon 1 from 23 of the samples. The PCR amplicons were cloned and sequenced, and the DNA sequence analysis of the cloned material was in agreement with the ARMS results in all but one case. This case represented a tumour that exhibited a five-nucleotide reversed inversion. The cloned sequence data confirm the sensitivity and specificity of the individual ARMS reactions and that it is possible in certain cases to detect additional, more complex, sequence variations.
引用
收藏
页码:1267 / 1274
页数:7
相关论文
共 50 条
  • [41] Characterisation of under-represented K-ras mutations in colorectal cancer
    Ellison, G
    Clayton, SJ
    Fox, JC
    Little, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A65 - A65
  • [42] K-Ras Mutation and Prognosis of Colorectal Cancer: A Meta-Analysis
    Rui Yuanyi
    Wang Cun
    Zhou Zongguang
    Zhong Xi
    Yu Yongyang
    HEPATO-GASTROENTEROLOGY, 2015, 62 (137) : 19 - 24
  • [43] K-Ras mutation status as a predictive biomarker in metastatic colorectal cancer
    Ramos, Francisco Javier
    Tabernero, Josep
    BIOMARKERS IN MEDICINE, 2008, 2 (02) : 97 - 99
  • [44] Detection of β-thalassemia mutations using a multiplex amplification refractory mutation system assay
    Mirasena, Saisiri
    Shimbhu, Dawan
    Sanguansermsri, Mondhon
    Sanguansermsri, Torpong
    HEMOGLOBIN, 2008, 32 (04) : 403 - 409
  • [45] K-ras point mutation detection in lung cancer:: Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification
    Clayton, SJ
    Scott, FM
    Walker, J
    Callaghan, K
    Haque, K
    Liloglou, T
    Xinarianos, G
    Shawcross, S
    Ceuppens, P
    Field, JK
    Fox, JC
    CLINICAL CHEMISTRY, 2000, 46 (12) : 1929 - 1938
  • [46] Detection of K-RAS oncogene mutations using PCR and pyrosequencing
    Cai, L.
    Kam-Morgan, L.
    Eisenberg, M.
    Anderson, S.
    EJC SUPPLEMENTS, 2009, 7 (04): : 12 - 13
  • [47] The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer
    Esteller, M
    Garcia, A
    MartinezPalones, JM
    Xercavins, J
    Reventos, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (10) : 1572 - 1577
  • [48] Detection of colorectal neoplasia associated K-Ras mutations in human urine.
    Brenner, D. E.
    Su, Y.
    Normolle, D. P.
    Syngal, S.
    Bresalier, R.
    Marcon, N.
    Baron, J.
    Block, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 50S - 50S
  • [49] Mutations in K-RAS are frequent in normal colorectal mucosa
    Olivecrona, Hans
    Zetterqvist, Henrik
    Lindforss, Ulrik
    GASTROENTEROLOGY, 2007, 132 (04) : A637 - A637
  • [50] APC and K-ras mutations in colorectal tumorigenesis.
    Umetani, N
    Masaki, T
    Sasaki, S
    Matsuda, K
    Muto, T
    GASTROENTEROLOGY, 1998, 114 (04) : A694 - A695